Table 3.
DFS and OS according to NSCLC p stage.
| Parameter | Total | NSCLC p stage | IA–III (n = 169) | II–III (n = 52) | |||
|---|---|---|---|---|---|---|---|
| (n = 171) | I (n = 117) | IIA (n = 7) | IIB (n = 17) | IIIA (n = 28) | |||
| DFS median (95% CI) | 31.5 (29.6–33.1) | 31.6 (29.4–33.5) | 35.8 (21.4–43.1) | 31.7 (19.6–36.9) | 29.3 (25.5–31.8) | NR (20.4–34.5) | 25 (20.4–34.5) |
| DFS, % | |||||||
| 12 months | 85.1 | 91.4 | 85.7 | 56.5 | 74.1 | 85.5 | 70.1 |
| 24 months | 75.6 | 85.9 | 53.6 | 43.9 | 59.3 | 75.9 | 53.9 |
| 36 months | 60.0 | 74.4 | 53.6 | 31.4 | 25.8 | 60.2 | 32.2 |
| OS, % | |||||||
| 12 months | 94.6 | 94.0 | 100.0 | 87.5 | 100.0 | 95.2 | 95.9 |
| 24 months | 91.5 | 93.0 | 100.0 | 87.5 | 88.5 | 92.0 | 89.8 |
| 36 months | 84.7 | 85.5 | 100.0 | 80.2 | 83.8 | 85.2 | 84.7 |
CI, confidence interval; DFS, disease-free survival; NSCLC, non-small-cell lung cancer; OS, overall survival.